Drug
Chikv Vlp Adjuvant
Chikv Vlp Adjuvant: highest development phase Phase 3, developed by Emergent BioSolutions. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Emergent BioSolutions
Trials
| Drug | Phase | Indication |
|---|---|---|
| CHIKV VLP/adjuvant NCT05072080 | Phase 3 | Chikungunya Virus |
Latest
No recent events.
Follow Chikv Vlp Adjuvant on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.